Patents Assigned to Tela Bio, Inc.
  • Patent number: 11864987
    Abstract: Stitching patterns overlap to produce a corner-locked stitch pattern. The corner-locked stitch pattern includes one or more thread interlace points, and one or more overlays of threads from overlapping patterns. A network of corner-lock stitch patterns produces a mesh, which may be embroidered into a substrate, such as a medical textile or biotextile. Corner-lock stitch patterns resist puncture-induced and tension-induced deformation of mesh pores between corner-locked stitch patterns, and may be used to modulate compliance and enhance strength properties of a substrate into which they are sewn.
    Type: Grant
    Filed: March 31, 2022
    Date of Patent: January 9, 2024
    Assignee: TELA Bio, Inc.
    Inventors: Skott Greenhalgh, John-Paul Romano
  • Publication number: 20230293281
    Abstract: A hybrid medical device that can aid in reconstructive or augmentative surgery of the breast is disclosed. The device can utilize a suitable biological collagen tissue matrix combined with a synthetic material, for example, that can impart a high initial strength to the repair site while permitting proper healing and revitalization of the implanted device.
    Type: Application
    Filed: March 13, 2023
    Publication date: September 21, 2023
    Applicant: Tela Bio, Inc
    Inventors: E. Skott GREENHALGH, John-Paul ROMANO
  • Patent number: 11628054
    Abstract: A hybrid medical device that can aid in reconstructive or augmentative surgery of the breast is disclosed. The device can utilize a suitable biological collagen tissue matrix combined with a synthetic material, for example, that can impart a high initial strength to the repair site while permitting proper healing and revitalization of the implanted device.
    Type: Grant
    Filed: July 6, 2020
    Date of Patent: April 18, 2023
    Assignee: Tela Bio, Inc
    Inventors: E. Skott Greenhalgh, John-Paul Romano
  • Patent number: 11590262
    Abstract: The apparatuses and methods described herein relates generally to the field of active agent (drug) release from surgical grafts useful for soft tissue reconstruction, regeneration, or repair. More particularly, described herein are surgical grafts for soft tissue repair that include active agent that is released over time while advantageously matching the biomechanical properties of tissue during healing and recovery.
    Type: Grant
    Filed: March 8, 2019
    Date of Patent: February 28, 2023
    Assignee: TELA BIO, INC.
    Inventor: E. Skott Greenhalgh
  • Patent number: 11464616
    Abstract: Materials for soft tissue repair, and in particular, material for hernia repair. These materials may be configured as an implant, such as a graft, that may be implanted into a patient in need thereof, such as a patient having a hernia or undergoing a hernia repair surgical procedure. These grafts may include a first layer comprising a substrate (e.g., mesh) and a second layer comprising a sheet of anti-adhesive material. The layers may be attached with a plurality of relatively small attachment sites that are separated by regions in which the two layers are not attached, to provide a highly compliant graft.
    Type: Grant
    Filed: February 14, 2020
    Date of Patent: October 11, 2022
    Assignee: TELA Bio, Inc.
    Inventors: Skott Greenhalgh, John-Paul Romano, Travis Speicher
  • Patent number: 11446130
    Abstract: Described herein are implants (e.g., medical textiles/biotextiles) that include stitched gripping filaments to increase gripping, and methods of forming and using them. In some configurations these apparatuses may be configured as surgical grafts that may be used for soft tissue reconstruction, regeneration, or repair.
    Type: Grant
    Filed: March 9, 2020
    Date of Patent: September 20, 2022
    Assignee: TELA Bio, Inc.
    Inventors: E. Skott Greenhalgh, John-Paul Romano, Travis Speicher, Brendan Farrell
  • Patent number: 11369464
    Abstract: Compliance control stitch patterns sewn or embroidered into biotextile or medical textile substrates impart reinforcing strength, and stretch resistance and control into such substrates. Compliance control stitch patterns may be customizable to particular patients, substrate implantation sites, particular degenerative or diseased conditions, or desired time frames. Substrates having compliance control stitch patterns sewn or embroidered into them may be used in tissue repair or tissue reconstruction applications.
    Type: Grant
    Filed: August 28, 2019
    Date of Patent: June 28, 2022
    Assignee: TELA Bio, Inc
    Inventors: Skott Greenhalgh, John-Paul Romano
  • Patent number: 11344397
    Abstract: Stitching patterns overlap to produce a corner-locked stitch pattern. The corner-locked stitch pattern includes one or more thread interlace points, and one or more overlays of threads from overlapping patterns. A network of corner-lock stitch patterns produces a mesh, which may be embroidered into a substrate, such as a medical textile or biotextile. Corner-lock stitch patterns resist puncture-induced and tension-induced deformation of mesh pores between corner-locked stitch patterns, and may be used to modulate compliance and enhance strength properties of a substrate into which they are sewn.
    Type: Grant
    Filed: February 25, 2019
    Date of Patent: May 31, 2022
    Assignee: TELA BIO, INC.
    Inventors: Skott Greenhalgh, John-Paul Romano
  • Publication number: 20200330211
    Abstract: A hybrid medical device that can aid in reconstructive or augmentative surgery of the breast is disclosed. The device can utilize a suitable biological collagen tissue matrix combined with a synthetic material, for example, that can impart a high initial strength to the repair site while permitting proper healing and revitalization of the implanted device.
    Type: Application
    Filed: July 6, 2020
    Publication date: October 22, 2020
    Applicant: Tela Bio, Inc
    Inventors: E. Skott GREENHALGH, John-Paul ROMANO
  • Publication number: 20200297476
    Abstract: Implantable tensile load-bearing grafts having synthetic components stitched through biological components are disclosed. The synthetic components can be biodegradable and/or non-biodegradable and of differing tensile strengths from each other and the biological component. Methods of making the grafts are also disclosed.
    Type: Application
    Filed: June 4, 2020
    Publication date: September 24, 2020
    Applicant: Tela Bio, Inc
    Inventors: E. Skott GREENHALGH, Antony KOBLISH
  • Patent number: 10702364
    Abstract: A hybrid medical device that can aid in reconstructive or augmentative surgery of the breast is disclosed. The device can utilize a suitable biological collagen tissue matrix combined with a synthetic material, for example, that can impart a high initial strength to the repair site while permitting proper healing and revitalization of the implanted device.
    Type: Grant
    Filed: July 19, 2016
    Date of Patent: July 7, 2020
    Assignee: Tela Bio, Inc.
    Inventors: E. Skott Greenhalgh, John-Paul Romano
  • Patent number: 10675141
    Abstract: Implantable tensile load-bearing grafts having synthetic components stitched through biological components are disclosed. The synthetic components can be biodegradable and/or non-biodegradable and of differing tensile strengths from each other and the biological component. Methods of making the grafts are also disclosed.
    Type: Grant
    Filed: September 21, 2016
    Date of Patent: June 9, 2020
    Assignee: Tela Bio, Inc
    Inventors: E. Skott Greenhalgh, Antony Koblish
  • Patent number: 10561485
    Abstract: Materials for soft tissue repair, and in particular, material for hernia repair. These materials may be configured as an implant, such as a graft, that may be implanted into a patient in need thereof, such as a patient having a hernia or undergoing a hernia repair surgical procedure. These grafts may include a first layer comprising a substrate (e.g., mesh) and a second layer comprising a sheet of anti-adhesive material. The layers may be attached with a plurality of relatively small attachment sites that are separated by regions in which the two layers are not attached, to provide a highly compliant graft.
    Type: Grant
    Filed: November 15, 2017
    Date of Patent: February 18, 2020
    Assignee: TELA Bio, Inc.
    Inventors: Skott Greenhalgh, John-Paul Romano, Travis Speicher
  • Patent number: 10500030
    Abstract: A hybrid medical device that can aid in reconstructive or augmentative surgery of the breast is disclosed. The device can utilize a suitable biological collagen tissue matrix combined with a synthetic material, for example, that can impart a high initial strength to the repair site while permitting proper healing and revitalization of the implanted device.
    Type: Grant
    Filed: July 19, 2016
    Date of Patent: December 10, 2019
    Assignee: Tela Bio, Inc
    Inventors: E. Skott Greenhalgh, John-Paul Romano
  • Patent number: 10426587
    Abstract: Compliance control stitch patterns sewn or embroidered into biotextile or medical textile substrates impart reinforcing strength, and stretch resistance and control into such substrates. Compliance control stitch patterns may be customizable to particular patients, substrate implantation sites, particular degenerative or diseased conditions, or desired time frames. Substrates having compliance control stitch patterns sewn or embroidered into them may be used in tissue repair or tissue reconstruction applications.
    Type: Grant
    Filed: July 21, 2016
    Date of Patent: October 1, 2019
    Assignee: TELA Bio, Inc.
    Inventors: Skott Greenhalgh, John-Paul Romano
  • Patent number: 10213284
    Abstract: Stitching patterns overlap to produce a corner-locked stitch pattern. The corner-locked stitch pattern includes one or more thread interlace points, and one or more overlays of threads from overlapping patterns. A network of corner-lock stitch patterns produces a mesh, which may be embroidered into a substrate, such as a medical textile or biotextile. Corner-lock stitch patterns resist puncture-induced and tension-induced deformation of mesh pores between corner-locked stitch patterns, and may be used to modulate compliance and enhance strength properties of a substrate into which they are sewn.
    Type: Grant
    Filed: June 29, 2016
    Date of Patent: February 26, 2019
    Assignee: TELA Bio, Inc.
    Inventors: Skott Greenhalgh, John-Paul Romano
  • Patent number: 10130457
    Abstract: A hybrid medical device that can aid in reconstructive or augmentative surgery of the breast is disclosed. The device can utilize a suitable biological collagen tissue matrix combined with a synthetic material, for example, that can impart a high initial strength to the repair site while permitting proper healing and revitalization of the implanted device.
    Type: Grant
    Filed: March 5, 2015
    Date of Patent: November 20, 2018
    Assignee: Tela Bio, Inc.
    Inventors: E. Skott Greenhalgh, John-Paul Romano
  • Patent number: 9925030
    Abstract: Stitching patterns overlap to produce a corner-locked stitch pattern. The corner-locked stitch pattern includes one or more thread interlace points, and one or more overlays of threads from overlapping patterns. A network of corner-lock stitch patterns produces a mesh, which may be embroidered into a substrate, such as a medical textile or biotextile. Corner-lock stitch patterns resist puncture-induced and tension-induced deformation of mesh pores between corner-locked stitch patterns, and may be used to modulate compliance and enhance strength properties of a substrate into which they are sewn.
    Type: Grant
    Filed: October 3, 2016
    Date of Patent: March 27, 2018
    Assignee: TELA Bio, Inc.
    Inventors: Skott Greenhalgh, John-Paul Romano
  • Patent number: 9820843
    Abstract: Materials for soft tissue repair, and in particular, material for hernia repair. These materials may be configured as an implant, such as a graft, that may be implanted into a patient in need thereof, such as a patient having a hernia or undergoing a hernia repair surgical procedure. These grafts may include a first layer comprising a substrate (e.g., mesh) and a second layer comprising a sheet of anti-adhesive material. The layers may be attached with a plurality of relatively small attachment sites that are separated by regions in which the two layers are not attached, to provide a highly compliant graft.
    Type: Grant
    Filed: April 26, 2017
    Date of Patent: November 21, 2017
    Assignee: TELA Bio, Inc.
    Inventors: Skott Greenhalgh, John-Paul Romano, Travis Speicher
  • Patent number: 9775700
    Abstract: Compliance control stitch patterns sewn or embroidered into biotextile or medical textile substrates impart reinforcing strength, and stretch resistance and control into such substrates. Compliance control stitch patterns may be customizable to particular patients, substrate implantation sites, particular degenerative or diseased conditions, or desired time frames. Substrates having compliance control stitch patterns sewn or embroidered into them may be used in tissue repair or tissue reconstruction applications.
    Type: Grant
    Filed: October 3, 2016
    Date of Patent: October 3, 2017
    Assignee: TELA Bio, Inc.
    Inventors: Skott Greenhalgh, John-Paul Romano